Skip to content
Fiscal Receipts

Senate LDA lobbying filing

Cardinal Health Inc

A public disclosure record: who filed, what they reported, and the program connections found in the text.
Registrant: Cardinal Health, Inc. Year: 2026 Period: Second Quarter Type: Q2

Filed as: CARDINAL HEALTH INC — CARDINAL HEALTH, INC.. Search lda.senate.gov for those strings; the names above are this site’s casing of them, nothing else.

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$460.0K

Connections in the record

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Lobbying activities4

  • Health IssuesHCR

    Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

  • ManufacturingMAN

    Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

  • Tariff (miscellaneous tariff bills)TAR

    Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to tariffs, trade, and U.S. trade policy.

  • Trade (domestic/foreign)TRD

    Issues related to tariffs, trade, and U.S. trade policy.

Lobbyists4

  • ABIGAIL BARNES
  • ANGELEINE COMTE
  • JERRICA MATHIS
  • REBECCA MCGRATH

Source: U.S. Senate Lobbying Disclosure Act database. Underlined dollar figures cite the filing record on lda.senate.gov and open to that citation. Amounts shown as “not reported” are absent from the filing itself.